Published On: March 6, 2024

We are thrilled to announce a significant milestone for the IMI-funded PROMISE project—our much-anticipated supplement has been published in “The Journal of Infectious Diseases”!  

Supplement_1, 15 March 2024 – Preparing Europe for Introduction of Immunization Against RSV: Bridging the Evidence and Policy Gap  

This upcoming release marks a culmination of extensive, high-quality research efforts focused on the respiratory syncytial virus (RSV), with far-reaching implications for public health policy and practice. 

The findings from the PROMISE project have not only expanded our understanding of RSV but have also informed critical policy decisions surrounding RSV surveillance. By providing evidence-based recommendations, our research is helping pave the way for the integration of RSV vaccines and monoclonal antibodies into national immunisation programmes across Europe. 

Read the supplement in The Journal of Infectious Diseases and join us in celebrating this significant achievement in RSV research. Together, we can make a difference. 

More news